Detalhe da pesquisa
1.
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Eur J Haematol
; 99(5): 409-414, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675766